13 12, 2023

Pfizer Falls to 10-Year Low on Weak Forecast for 2024: 3 Reasons to Sell This Stock ASAP

By |2023-12-13T17:56:27+00:00December 13th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , , |

Pfizer (PFE) fell 9% in Wednesday morning trading after the company’s weak forecast for 2024 left much to be desired in the eyes of investors and analysts alike. The stock is headed toward a 10-year low, and has now shed 50% of its value in the last year alone. The drugmaker has been steadily [...]

16 10, 2023

Why is Pfizer Up 5% After Cutting Sales Outlook? 3 Things Investors Need to See

By |2023-12-07T19:49:39+00:00October 16th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , , |

Pfizer (PFE) ended last week on a sour note, announcing after the market closed on Friday that it will cut $9 billion from its sales outlook. And yet, the stock is up more than 5% so far in Monday morning’s trading session. The full-year EPS has been adjusted to $1.45 to $1.65 on revenue [...]

Go to Top